<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="/css/uswds.min.css">
    <link rel="stylesheet" href="/css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/html/titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/html/parts/21CFR520.html">Part 520
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 520.2483  Triamcinolone.
                            </h3>
                            <p class="depth1"><em>(a)</em> Specifications. (1) Each tablet contains 0.5 milligram (mg) or 1.5 mg triamcinolone acetonide.</p><p class="depth2"><em>(1)</em> Each tablet contains 0.5 milligram (mg) or 1.5 mg triamcinolone acetonide.</p><p class="depth2"><em>(2)</em> Each 15 grams of powder contains 10 mg triamcinolone acetonide.</p><p class="depth1"><em>(b)</em> Sponsor. See No. 000010 in Sec. 510.600(c) of this chapter.</p><p class="depth1"><em>(c)</em> Special considerations. See Sec. 510.410 of this chapter.</p><p class="depth1"><em>(d)</em> Conditions of use--(1) Dogs and cats. Use tablets described in paragraph (a)(1) of this section as follows:</p><p class="depth2"><em>(1)</em> Dogs and cats. Use tablets described in paragraph (a)(1) of this section as follows:</p><p class="depth3"><em>(i)</em> Amount. Administer 0.05 mg per pound (/lb) of body weight daily by mouth; up to 0.1 mg per pound (/lb) of body weight daily, if response to the smaller dose is inadequate. Therapy may be initiated with a single injection of triamcinolone acetonide suspension as in Sec. 522.2483 of this chapter, in which case triamcinolone acetonide tablets should be administered beginning 5 to 7 days after the injection.</p><p class="depth3"><em>(ii)</em> Indications for use. As an anti-inflammatory agent.</p><p class="depth3"><em>(iii)</em> Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.</p><p class="depth2"><em>(2)</em> Horses. Use oral powder described in paragraph (a)(2) of this section as follows:</p><p class="depth3"><em>(i)</em> Amount. Administer 0.005 to 0.01 mg/lb of body weight twice daily, sprinkled (top-dressed) on a small portion of feed. Therapy may be initiated with a single injection of triamcinolone acetonide suspension as in Sec. 522.2483 of this chapter, in which case triamcinolone acetonide oral powder should be administered beginning 3 or 4 days after the injection.</p><p class="depth3"><em>(ii)</em> Indications for use. As an anti-inflammatory agent.</p><p class="depth3"><em>(iii)</em> Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in horses intended for human consumption.
[75 FR 10166, Mar. 5, 2010]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
